B. Metzler Seel. Sohn & Co. Ag Karuna Therapeutics, Inc. Transaction History

B. Metzler Seel. Sohn & Co. Ag

  • $9.49 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$161.01 - $317.85 $386,101 - $762,204
2,398 Added 148.39%
4,014 $1.27 Million
Q3 2023

Nov 13, 2023
SELL
$164.66 - $218.08 $298,363 - $395,160
-1,812 Reduced 52.86%
1,616 $273,000
Q2 2023

Aug 11, 2023
BUY
$176.32 - $240.22 $604,424 - $823,474
3,428 New
3,428 $743,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email